Skip to main content

Table 5 Mean (range) monthly stock out in days for CVD medicines and antidiabetics

From: The knock-on effects of COVID-19 pandemic on the supply and availability of generic medicines in Ethiopia: mixed methods study

Medicines products

Average monthly day of stock out (days)

Overall

Before COVID-19

During COVID-19

Insulin products

10.5(7–12.5)

7.6 (4.4–13.2)

13(9.5–18)

Oral hypoglycemic agents

8.7(5- 11.5)

8.7 (2.3–12)

10.6(4–14)

Aspirin

12.5(8.2–16.8)

9 (6–14)

16(10–23)

Diuretics

6.6(4.2–9)

5.5 (3–8)

7.4 (4.2–10.6)

Beta-blockers

7.7 (6.3–9)

6.5 (5.6–7.4)

8.6 (7.8–9.5)

ACE inhibitors/ARBs

7.7(6–9.5)

5.3(2.2–8.4)

9(5–13.4)

Statins

11.6 (9.4–13.8)

8.6(6.8–10.4)

13.6(11.6–15.8)

Calcium Channel blockers

6.6 (5.3–7.9)

4.7(3.5–6.7)

7.9 (6–9.7)

Digoxin products

9.5 (5.8–13.2)

8.8 (5.6–12.4)

10.4(7.2–13.6)

Methyldopa

16 (10.6–21.4)

13(8.7–17.3)

16(14.6–21.4)

  1. ACE Angiotensin-converting enzyme, ARBs angiotensin receptor blockers